Apnimed
PrivateLast Round
Debt
Mar 27, 2026
Total Funding Raised
$207.85M
Company Overview
Apnimed is a healthcare company that develops pharmacologic therapies aimed at treating obstructive sleep apnea (OSA) through simple, orally dosed medications that target the underlying neurobiological mechanisms of airway obstruction.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2B2C
Customer Profile
Hardware Sales, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Apnimed Comps
Public and private peers based on sector, stage, and business model.
Apnimed Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Mar 27, 2026 | ||||
| IPO Announced | Jun 6, 2025 | ||||
| Series C Extension | Dec 22, 2022 | ||||
| Series C | Apr 28, 2022 | ||||
| Series B | Mar 25, 2021 | ||||
Series A Extension | Mar 31, 2020 |
Apnimed Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Ameriprise | Series B |
| HealthCare Royalty Partners | Debt |
| Alpha Wave Ventures | Series C, Series C Extension |
| Columbia Threadneedle Investments | Series C Extension |
| Morningside Ventures | Series C, Series A, Series B |
| J. & W. Seligman & Company | Series B |
| Sectoral | Series C Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 1, 2026
Job posting indicates AD109 is preparing for launch.
- Mar 27, 2026
$25M debt round raised.
Apnimed Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Apnimed's valuation, stock price, and market status.
